Finance

Lists
Why is MRKR up 3,95%?
Dive Deeper
MRKR:NASDAQ
Marker Therapeutics Inc
USD 1,01
+3,95%
(+0,038) 1D
12 Okt., 16:00:02 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
USD 0,98
High
USD 1,03
Low
USD 0,98
Mkt. cap
16,87 m
Avg. vol.
72,50 k
Volume
107,78 k
52-wk high
USD 2,46
52-wk low
USD 0,84
EPS
-USD 0,47
Beta
1,53
Shares outstanding
16,67 m
No. of employees
5
Open
USD 0,98
High
USD 1,03
Low
USD 0,98
Mkt. cap
16,87 m
Avg. vol.
72,50 k
Volume
107,78 k
52-wk high
USD 2,46
52-wk low
USD 0,84
EPS
-USD 0,47
Beta
1,53
Shares outstanding
16,67 m
No. of employees
5
News stories
From web sources and news partners
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
HeadquartersHouston, Texas, Verenigde State van Amerika
Sector-
Websitemarkertherapeutics.com
Analyst ratings
Based on 2 analysts giving stock ratings to MRKR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MRKR in the last 3 months.
Highest
Current USD 1,01
USD 10,00 (+890,10%)
Average
USD 9,00 (+791,09%)
Lowest
USD 8,00 (+692,08%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
USD 10,00
+890,1%
09/21/2026
John Newman
Canaccord Genuity
Buy
Maintained
USD 8,00
+692,1%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,23 m
1,10 m
751,69 k
681,58 k
Cost of goods sold
2,35 m
2,14 m
2,84 m
1,48 m
Cost of revenue
2,35 m
2,14 m
2,84 m
1,48 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,02 m
846,61 k
1,23 m
1,14 m
Operating expense
1,02 m
846,61 k
1,23 m
1,14 m
Total operating expenses
3,37 m
2,99 m
4,07 m
2,62 m
Operating income
-2,14 m
-1,88 m
-4,07 m
-2,62 m
Other non operating income
-
-
760,37 k
681,58 k
EBT including unusual items
-2,00 m
-1,72 m
-3,18 m
-1,83 m
EBT excluding unusual items
-2,00 m
-1,72 m
-3,18 m
-1,83 m
Income tax expense
-
-15,16 k
-
-
Effective tax rate
-
0,88%
-
-
Other operating expenses
-
-
-
-
Net income
-2,00 m
-1,70 m
-3,18 m
-1,83 m
Net profit margin
-162,11%
-154,35%
-
-
Earnings per share
-0,12
-0,04
-0,16
-0,09
Interest and investment income
138,06 k
165,63 k
132,89 k
112,56 k
Interest expense
-
-
-
-
Net interest expenses
138,06 k
165,63 k
132,89 k
112,56 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme